ELABORATION OF ORGANIZATIONAL ARRANGEMENTS ON THE IMPROVEMENT OF FUNCTIONING OF THE SYSTEM OF PHARMACEUTICAL SUPPORT OF SUDAN POPULATION
Abstract
In the article is considered the problem of support of Sudan population with available pharmaceutical production. The aim of research is an analysis of the price and assortment policy realized by the different pharmaceutical structures, determination of the level of their functions on guaranteeing the availability of medicaments, elaboration on the base of received results the arrangements on optimization of the pharmaceutical support system. It was determined that not all subjects of Sudan pharmaceutical market responsible for the pharmaceutical support cope with such problems at the proper level. Thus in the private drugstores, in the net drugstores of the Ministry of defense «Alia» and in drugstores of the health insurance system the prices of medicament exceed the recommended ones in more than 2 times, an assortment also does not corresponds to both internal and international requirements. The received results indicate the unreasonable use of budget means by the separate state structures, the negative tendencies in the system of guaranteeing the availability of pharmaceutical help.
It was established that the biggest suppliers of the medicaments in Sudan, excluding the state Centre of medicament support CMS cannot ensure the system of health protection with medicaments of the proper quality, assortment and the price rate.
There were elaborated the organizational-economic approaches to optimization of the structure of medical support of Sudan that include the change of the flows of medicaments distribution. There was offered the structure that unites all inflows in the aforesaid CMS and then distributes resources according to the needs of organizations and regions.
Introduction of the offered structures will allow improve the system of purchase and distribution of medicaments, make it transparent. The result of change will be the rise of physical and economic availability of medicaments, widening of assortment, decrease of the price of preparations, significant economy of budget resources.
Keywords
Full Text:
PDFReferences
Roshhin, G. E. (2013). Mezhdunarodnye korporacii v Afrike. Azija i Afrika segodnja, 12, 30–33.
Sudan: ser’eznye problemy s medicinoj. Available at: http://peopleandcountries.com/article-784-1.html
Eastern Mediterranean Region. Framework for health information systems and core indicators for monitoring health situation and health system performance (2015). WHO. Available at: http://applications.emro.who.int/dsaf/EMROPUB_2015_EN_1904.pdf?ua=1&ua=1
Annual Statistical Report 2014. Annual Health Statistics Reports 2014. Federal Ministry of Health (Sudan). National Center for Health Information. Available at: http://www.sho.gov.sd/controller/kn_hub_%20featured.php?sm_id=133&mid=110&lid=1#
Sudan. Oficial’nye sajty. Available at: http://polpred.com/?cnt=148&cat=5
Sudan: statisticheskie dannye. WHO. Available at: http://www.who.int/countries/sdn/ru/
Organizacija zdravoohranenija v razvivajushhihsja stranah. Available at: http://helpiks.org/2-34536.html
FIP global Pharmacy: Workforce Report (2012). Available at: https://www.fip.org/static/fipeducation/2012/FIP-Workforce-Report-2012/?page=hr2012#/54
Bate, R., Jin, G. Z., Mathur, A. (2011). Does price reveal poor-quality drugs? Evidence from
countries. Journal of Health Economics, 30 (6), 1150–1163. doi: 10.1016/j.jhealeco.2011.08.006
Niens, L., Van de Poel, E., Cameron, A., Ewen, M., Laing, R., Brouwer, W. (2012). Practical measurement of affordability: an application to medicines. Bulletin of the World Health Organization, 90 (3), 219–227. doi: 10.2471/blt.10.084087
Health System Financing Review Report (2014). Sudan Federal Ministry of Health. Available at: http://docplayer.net/3744434-Health-system-financing-review-report-may-2014-sudan-federal-ministry-
of-health.html
NMP 2005. National Medicine Policy (2005). Khartoum (Sudan): Federal Ministry of Health, 311.
Gamal, K. M. A., Abdeen, M. O. (2012). Pharmaceuticals in Sudan: Development in regulations, governance and implementation of national drug policies. African Journal of Pharmacy and Pharmacology, 6 (1), 1–12. doi: 10.5897/ajpp11.023
Global pharmacy. Workforce report (2012). Federation Internationale Pharmaceutique (FIP). Hague. FIP publishing, 85.
Creese, A. (2011). Sales Taxes on Medicines. WHO/HAI Project on Medicine Prices and Availability. Pharmaceutical Pricing Policies and Interventions, 49. Available at: http://docplayer.net/228639-Who-hai-project-on-medicine-prices-and-availability-review-series-on-pharmaceutical-pricing-policies-and-interventions.html
Medicine Prices, Availability and Affordability in Sudan. Report of a survey conducted in February – March 2013 (2013). Available at: http://www.haiweb.org/medicineprices/surveys/201302SD/sdocs/Sudan_survey_report_2013.pdf
Ali, H., Mahmoud, R. (2013). Analysis of price discrepancies and its impact on rational use of medicines. Sudan Medical Monitor, 8 (4), 189. doi: 10.4103/1858-5000.133021
Gamal, K. M. (2007). The impact of the pharmaceutical regulations on the quality of medicines On the Sudanese market: Importers’ perspective. Sudanese Journal of Public Health, 2 (3), 157–167.
Kheder, S., Ali, H. (2014). Evaluating medicines prices, availability, affordability and price components in Sudan. Sudan Medical Monitor, 9 (1), 19. doi: 10.4103/1858-5000.144655
WHO/HAI Project on Medicine Prices and Availability (2011). Pharmaceutical Pricing Policies and Interventions. Available at: http://haiweb.org/wp-content/uploads/2015/08/ERP-final-May2011a1.pdf
The African Regional Health Report. WHO. Available at: http://www.who.int/mediacentre/news/releases/2006/pr68/ru/
Database of The American Society of Health-System Pharmacists resources (ASHP) (2012). Available at: http://www.ashp.org
Gamal, K. M. A., Abdeen, M. O. (2011). Privatisation of the Central Medical Supplies (CMS) public corporation: Why not? Research In Pharmaceutical Biotechnology, 3 (8), 104–110.
Gamal, K. M. A. (2010). Can the Public Central Medical Supplies Corporation of Sudan balance a policy for delivering low-cost medicines whilst maintaining quality? Sudanese Journal of Public Health, 5 (3), 115–121.
Millennium Development Goals (MDGs). WHO. Available at: http://www.who.int/topics/millennium_development_goals/about/ru/
NMSF Supply Chain Model: States’ Medical Supply Fund (2013). Khartum: FMOH-NMSF, 29. Available at: http://www.nmsf.gov.sd/includes/pdf/supply_model.pdf
Mahgoub, M. H., Mohamed I. B. M. I. (2009). Do systems contribute to the sustainability of the Revolving Drug Fund (RDF) in Sudan? Sudanese Journal of Public Health, 4 (2), 288–295.
DOI: http://dx.doi.org/10.21303/2504-5679.2016.00093
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 Elena Ievtushenko, Abuzayid Osama Mohamed Nur Ahmed

This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)